García-Herrera BA, Cuéllar-Guzmán LF

Language: Spanish
References: 23
Page: 273-277
PDF size: 231.31 Kb.

ABSTRACT

Cancer is one of the main causes of global mortality and is positioned as the second leading cause of death after cardiovascular diseases, causing approximately 1 in 6 deaths. Gynecological malignancies constitute a serious public health problem as they remain a major cause of cancer-related mortality, with an estimated annual incidence of more than 3.6 million cases and more than 1.3 million deaths. They represent almost 40% of all cancer incidences and more than 30% of all cancer-related deaths in women worldwide. Anesthesia and specific intensive care for gynecological-oncological surgeries require extensive specialized knowledge for better perioperative management of these cases and to reduce postoperative complications and improve overall and cancer-free survival after surgery. The advanced specialization in oncoanesthesia and the Pain Out program, through its two projects in Mexico, have enhanced our understanding of the needs of cancer patients, thereby enabling us to achieve anesthetic and analgesic management with clear oncological objectives. In this narrative review, we aim to examine the key components of providing anesthesia and analgesia for major surgical procedures for gynecologic tumors. The MEDLINE^®, PubMed, Springer, UpToDate, and EMBASE^™ databases were searched for peer-reviewed articles discussing anesthetic management in oncologic surgeries.

REFERENCES

1. Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024. doi: 10.3322/caac.21834

2. Frick C, Rumgay H, Vignat J, Ginsburg O, Nolte E, Bray F, et al. Quantitative estimates of preventable and treatable deaths from 36 cancers worldwide: a population-based study. Lancet Glob Health. 2023;11:e1700-e1712.

3. Nelson G, Bakkum-Gamez J, Kalogera E, Glaser G, Altman A, Meyer LA, et al. Guidelines for perioperative care in gynecologic/oncology: enhanced Recovery After Surgery (ERAS) Society recommendations-2019 update. Int J Gynecol Cancer. 2019;29:651-668.

4. Waller A, Forshaw K, Bryant J, Carey M, Boyes A, Sanson-Fisher R. Preparatory education for cancer patients undergoing surgery: a systematic review of volume and quality of research output over time. Patient Educ Couns. 2015:S0738-3991(15)00229-3.

5. Elsherbiny, M. Tsampras, N. Modern considerations for perioperative care in gynaecology. Obstet Gynaecol Reprod Med. 2022;32:14-20.

6. Madill M, Kertz H, Gavard J, Chand S, Wilson O, Shelley N, et al. P16 Optimizing prehabilitation in gynecologic oncology. Gynecol Oncol. 2022;165:S14. doi: 10.1016/s0090-8258(22)00361-4

7. Guran E, Hu J, Wefel JS, Chung C, Cata JP. Perioperative considerations in patients with chemotherapy-induced cognitive impairment: a narrative review. Br J Anaesth. 2022;129:909-922.

8. Parashar S, Akhter N, Paplomata E, Elgendy IY, Upadhyaya D, Scherrer-Crosbie M, et al. Cancer treatment-related cardiovascular toxicity in gynecologic malignancies: JACC: CardioOncology State-of-the-Art review. JACC CardioOncol. 2023;5:159-173.

9. Santos MLC, de Brito BB, da Silva FAF, Botelho ACDS, de Melo FF. Nephrotoxicity in cancer treatment: an overview. World J Clin Oncol. 2020;11:190-204.

10. Khadraoui H, Herzog TJ, Jackson A, Billingsley C. Acute pulmonary complications in the setting of high risk gestational trophoblastic neoplasia and induction of chemotherapy. Gynecol Oncol Rep. 2023;48:101224.

11. Viau M, Renaud MC, Grégoire J, Sebastianelli A, Plante M. Paraneoplastic syndromes associated with gynecological cancers: a systematic review. Gynecol Oncol. 2017;146:661-671.

12. De Ruysscher D, Niedermann G, Burnet NG, Siva S, Lee AWM, Hegi-Johnson F. Radiotherapy toxicity. Nat Rev Dis Primers. 2019;5:13.

13. Wu W, He X, Li S, Jin M, Ni Y. Pain nursing for gynecologic cancer patients. Front Oncol. 2023;13:1205553.

14. Stamer UM, Ehrler M, Lehmann T, Meissner W, Fletcher D. Pain-related functional interference in patients with chronic neuropathic postsurgical pain: an analysis of registry data. Pain. 2019;160:1856-1865.

15. Nelson G, Fotopoulou C, Taylor J, Glaser G, Bakkum-Gamez J, Meyer LA, et al. Enhanced Recovery After Surgery (ERAS^®) society guidelines for gynecologic oncology: addressing implementation challenges - 2023 update. Gynecol Oncol. 2023;173:58-67.

16. Cho JS, Seon K, Kim MY, Kim SW, Yoo YC. Effects of perioperative dexmedetomidine on immunomodulation in uterine cancer surgery: a randomized, controlled trial. Front Oncol. 2021;11:749003.

17. Rodriguez-Arango JA, Zec T, Khalife M. Perioperative ketamine and cancer recurrence: a comprehensive review. J Clin Med. 2024;13:1920.

18. Alam A, Rampes S, Patel S, Hana Z, Ma D. Anesthetics or anesthetic techniques and cancer surgical outcomes: a possible link. Korean J Anesthesiol. 2021;74:191-203.

19. Zhang Y, Jing Y, Pan R, Ding K, Chen R, Meng Q. Mechanisms of cancer inhibition by local anesthetics. Front Pharmacol. 2021;12:770694.

20. Weibel S, Jelting Y, Pace NL, Helf A, Eberhart LH, Hahnenkamp K, et al. Continuous intravenous perioperative lidocaine infusion for postoperative pain and recovery in adults. Cochrane Database Syst Rev. 2018;6:23-34.

21. Ariza F, Rodriguez-Mayoral H, Villarreal K. Analgesia epidural en cirugía abdominal mayor: pros, contras y puntos sin resolver más allá del control del dolor. Rev Colomb Anestesiol. 2018;46:183-184.

22. Dockrell L, Buggy DJ. The role of regional anaesthesia in the emerging subspecialty of onco-anaesthesia: a state-of-the-art review. Anaesthesia. 2021;76:148-159.

23. Garduño-López AL, Nuche-Cabrera E, Monroy-Álvarez C. Dolor postoperatorio: optimización del manejo en el contexto perioperatorio. Rev Mex Anest. 2016;39:16-19.